| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / TOPICAL | 0.18 %w/w | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRACAUDAL | | 210 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRATHECAL | | 9 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / OPHTHALMIC | 0.9 %w/v | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / NASAL | 14 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVITREAL | | 6 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER, FOR SOLUTION / ORAL | | 13 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO / TOPICAL | 0.15 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| MAGNESIUM ALUMINUM SILICATE | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | SUSPENSION / ORAL | 5000 mg/5ml | | Exact identifier — unii candidate 17 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | | 3535 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LIQUID / ORAL | | 162 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / TOPICAL | | 420 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | ELIXIR / ORAL | 200 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRAMUSCULAR | | 1486 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / AURICULAR (OTIC) | | 3 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | | 45 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVASCULAR | 0.86 %w/v | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAVASCULAR | NA | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | | 1126 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | CAPSULE, EXTENDED RELEASE / ORAL | NA | | Exact identifier — unii candidate 15 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM / VAGINAL | | 3 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / NASAL | 7.4 mg/1ml | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / RECTAL | | 1808 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SOLUTION / INTRAMUSCULAR | | 5 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRALESIONAL | | 13 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SYRUP / ORAL | | 40 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | SYRUP / ORAL | 28.4 mg/1ml | | Exact identifier — unii candidate 15 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / TOPICAL | | 210 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | | 388 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | | Exact identifier — unii candidate 3 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY, METERED / NASAL | | 36 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IRRIGATION | 2 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRABURSAL | 9 mg | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SOLUTION / OPHTHALMIC | 0.9 %w/w | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRALESIONAL | 0.15 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE / ORAL | | 1 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, EMULSION / INTRAVENOUS | 0.62 %w/v | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| CYCLOMETHICONE 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | | 260 mg | Exact identifier — unii candidate 3 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | JELLY / NASAL | 140 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INFILTRATION | 0.35 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | | 57 mg | Exact identifier — unii candidate 6 equally ranked IID candidates |
| MAGNESIUM ALUMINUM SILICATE | MAGNESIUM ALUMINUM SILICATE | 6M3P64V0NC | SUSPENSION/ DROPS / ORAL | 4.15 mg/2.5ml | | Exact identifier — unii candidate 17 equally ranked IID candidates |
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | LOTION / TOPICAL | NA | | Exact identifier — unii candidate 21 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS | NA | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CONCENTRATE / ORAL | 2.5 mg/5ml | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | | Exact identifier — unii candidate 21 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / NASAL | 140 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVENOUS | | 28773 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | | Exact identifier — unii candidate 2 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / RETROBULBAR | | 648 mg | Exact identifier — unii candidate 134 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | FILM / BUCCAL | 0.22 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | | 90 mg | Exact identifier — unii candidate 26 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 0.86 %w/v | | Exact identifier — unii candidate 134 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | DROPS / ORAL | NA | | Exact identifier — unii candidate 15 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | | Exact identifier — unii candidate 26 equally ranked IID candidates |